161 related articles for article (PubMed ID: 19767212)
1. Aprotinin in lung transplantation is associated with an increased incidence of primary graft dysfunction.
Marasco SF; Pilcher D; Oto T; Chang W; Griffiths A; Pellegrino V; Chan J; Bailey M
Eur J Cardiothorac Surg; 2010 Feb; 37(2):420-5. PubMed ID: 19767212
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation.
Herrington CS; Prekker ME; Arrington AK; Susanto D; Baltzell JW; Studenski LL; Radosevich DM; Kelly RF; Shumway SJ; Hertz MI; Bittner HB; Dahlberg PS
Clin Transplant; 2011; 25(1):90-6. PubMed ID: 20731686
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
[TBL] [Abstract][Full Text] [Related]
4. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation.
Bittner HB; Richter M; Kuntze T; Rahmel A; Dahlberg P; Hertz M; Mohr FW
Eur J Cardiothorac Surg; 2006 Feb; 29(2):210-5. PubMed ID: 16386921
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT
Am J Nephrol; 2008; 28(4):576-82. PubMed ID: 18264006
[TBL] [Abstract][Full Text] [Related]
6. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
7. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP
Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
[TBL] [Abstract][Full Text] [Related]
8. Lessons learned in antifibrinolytic therapy: The BART trial.
Murkin JM
Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):127-31. PubMed ID: 19622534
[TBL] [Abstract][Full Text] [Related]
9. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
[TBL] [Abstract][Full Text] [Related]
10. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity reactions to aprotinin re-exposure in paediatric surgery.
Siehr S; Stuth E; Tweddell J; Hoffman G; Troshynski T; Jones D; Mitchell M; Ghanayem N
Eur J Cardiothorac Surg; 2010 Feb; 37(2):307-11. PubMed ID: 19767215
[TBL] [Abstract][Full Text] [Related]
12. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin and renal dysfunction after pediatric cardiac surgery.
Székely A; Sápi E; Breuer T; Kertai MD; Bodor G; Vargha P; Szatmári A
Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
15. Use of aprotinin in pediatric organ transplantation.
Spray TL
Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S71-3; discussion S74-6. PubMed ID: 9647143
[TBL] [Abstract][Full Text] [Related]
16. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
17. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.
Gagne JJ; Griesdale DE; Schneeweiss S
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):259-68. PubMed ID: 19185048
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
[TBL] [Abstract][Full Text] [Related]
19. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin.
Dietrich W; Busley R; Boulesteix AL
Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563
[TBL] [Abstract][Full Text] [Related]
20. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
